Antipsychotic Polypharmacy versus Monotherapy and their Metabolic Side Effects in Patients with Schizophrenia
Dina Mohammed Abd El-Moniem El-Gabry;
Abstract
The prescribing of more than one antipsychotic at the same time is becoming common in the treatment of patients with severe mental illnesses, despite authoritative treatment guidelines that advocate for antipsychotic monotherapy, recommending antipsychoti
Other data
| Title | Antipsychotic Polypharmacy versus Monotherapy and their Metabolic Side Effects in Patients with Schizophrenia | Other Titles | التعدد الدوائي مقابل العلاج الأحادي لمضادات الذهان وتأثيراتها الجانبية الأيضية فى مرضى الفصام | Authors | Dina Mohammed Abd El-Moniem El-Gabry | Keywords | Antipsychotic Polypharmacy versus Monotherapy and their Metabolic Side Effects in Patients with Schizophrenia | Issue Date | 2013 | Description | The prescribing of more than one antipsychotic at the same time is becoming common in the treatment of patients with severe mental illnesses, despite authoritative treatment guidelines that advocate for antipsychotic monotherapy, recommending antipsychoti |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 119022Binder1.pdf | 365.19 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.